Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of LAMB1 mRNA | affects cotreatment|increases expression | 18585445
|
D001151 |
Arsenic |
Arsenic results in decreased expression of LAMB1 mRNA | decreases expression | 19654921
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of LAMB1 mRNA | affects cotreatment|increases expression | 18585445
|
C447119 |
bazedoxifene acetate |
bazedoxifene acetate results in increased expression of LAMB1 mRNA | increases expression | 19914376
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LAMB1 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LAMB1 mRNA | affects cotreatment|increases expression | 16054899
|
D019833 |
Genistein |
Genistein results in decreased expression of LAMB1 mRNA | decreases expression | 16169203
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of LAMB1 protein mutant form | increases expression | 18809619
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LAMB1 mRNA | affects cotreatment|increases expression | 16054899
|
D008942 |
Mitoxantrone |
LAMB1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
D010303 |
Paromomycin |
Paromomycin results in increased expression of LAMB1 protein mutant form | increases expression | 18809619
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LAMB1 mRNA | affects cotreatment|increases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LAMB1 mRNA | decreases expression | 18495758
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LAMB1 mRNA | decreases expression | 20106945
|
D013755 |
Tetradecanoylphorbol Acetate |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA | affects cotreatment|affects expression | 16979875
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of LAMB1 mRNA | increases expression | 17138961
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of LAMB1 mRNA | increases expression | 16236135
|
D015032 |
Zinc |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA | affects cotreatment|affects expression | 16979875
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.84 | 11752688 15322242 14514962 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.39 | 17202136 17190629 16889938 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
4.52 | 11274264 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.47 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.21 | 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.22 | 11874814 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
4.59 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.59 | 16410023 16325427 16580781 17119284 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.88 | 16916123 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.86 | 12569548 18414634 16251483 16835338 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.48 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.48 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.05 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
5.05 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.24 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15523497 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.88 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.88 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.68 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.87 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.87 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.58 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.68 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.68 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.68 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
10.83 | 17687452 18922899 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
10.83 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.83 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
10.83 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.06 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
12.20 | 19152805 15738583 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
12.20 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
12.20 | 16936243 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.29 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.08 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.51 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.90 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.74 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
marker/mechanism |
|
| 19915572 |
MESH:D003103 |
Coloboma |
marker/mechanism |
|
| 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
3.93 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.93 | 17182828 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
5.43 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.43 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.43 | 9224671 9142499 9211117 17551590 14991402 10589399 9664655 16925845 8800419 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
5.43 | 19302082 |
MESH:D003457 |
Cryptosporidiosis |
|
Paromomycin |
7.09 | 16547730 |
MESH:D003483 |
Cutis Laxa |
marker/mechanism |
|
| |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.39 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
9.52 | 17446233 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
9.52 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.18 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
7.18 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.18 | 17107852 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.68 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.53 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
8.34 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.34 | 11462148 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.44 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
16.38 | 19703484 |
MESH:D004487 |
Edema |
|
rosiglitazone |
16.38 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
16.38 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
16.38 | 8113982 15177302 7812673 16716910 9599246 11698051 8273558 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.95 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.95 | 18230668 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.58 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.51 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.51 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.85 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.78 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.93 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
7.93 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.65 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.65 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.65 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.56 | 6392382 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.80 | 17241300 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.16 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.16 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.95 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.17 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
4.86 | 18024279 15968427 17868369 19130971 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.50 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.50 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.14 | 16019553 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.59 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.77 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.51 | 17241300 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.68 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.06 | 7520565 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 18606429 15340226 16959395 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
8.01 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.01 | 16870215 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.70 | 17652376 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.44 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
12.32 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
12.32 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
12.32 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
12.32 | 18850075 18670907 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.56 | 16093927 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.44 | 18306037 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
3.70 | 12948887 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
11.95 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
11.95 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.95 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
11.95 | 15177302 7812673 11698051 8273558 7562506 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.78 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.62 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.87 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.87 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.44 | 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.98 | 12749816 16930632 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
5.73 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.23 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
10.23 | 18289764 19349640 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
10.23 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.40 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.72 | 12371664 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
5.38 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
9.52 | 10219319 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Paromomycin |
9.52 | 8889330 10219319 7570843 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Paromomycin |
5.66 | 8394861 17035822 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.38 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.38 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.78 | 18172266 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.68 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.71 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.71 | 17107899 16140955 9834237 19029980 16891316 16331271 19642359 16766008 16788101 15748426 17649720 19225113 17339181 17506722 16823087 17301526 17294898 16935935 19075265 12679006 17361223 19035177 17712046 17217047 17368321 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
6.73 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.73 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
6.73 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.73 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.73 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.54 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
4.54 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.09 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.89 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
4.89 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.89 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
4.89 | 11807781 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.27 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
14.27 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
14.27 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
14.27 | 12773700 |
MESH:D008382 |
Marfan Syndrome |
marker/mechanism |
|
| |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.52 | 1916698 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.36 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.49 | 15867202 16118317 15744524 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.28 | 18694830 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.50 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.50 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.85 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.94 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.94 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.64 | 17141266 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.42 | 16640825 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.42 | 16946489 16594593 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
16.30 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.30 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.30 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.38 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.38 | 9142499 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.36 | 17056641 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.24 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.07 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.93 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.93 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.93 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.88 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.49 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.49 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.28 | 12065085 18404319 18922899 8330346 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.27 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.16 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.98 | 16905509 6392382 15371236 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.53 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.16 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.18 | 11222880 11399792 11896295 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.74 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.74 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.74 | 16517595 16700911 12429649 16606632 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
15.49 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
15.49 | 15033597 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
15.49 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
4.98 | 17132701 15728788 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.00 | 11700416 18379247 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.50 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.11 | 16584753 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.28 | 18644591 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.08 | 16116481 16283617 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.74 | 17548696 15952646 16353154 17453740 17938729 16759981 16702368 17050553 19834688 18709164 6392382 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
17.84 | 17029826 17050553 17976673 16251483 15504454 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
17.84 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.84 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
17.84 | 8985016 12065085 18404319 11807781 8330346 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
17.84 | 16467112 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.31 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.47 | 15138204 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.01 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.92 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
9.92 | 16543248 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
2.81 | 18640142 11144890 19429237 17976673 17306315 19322015 15987713 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.66 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
11.77 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
11.77 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.73 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.50 | 18776599 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |